Feasibility trial of 3-phase adaptive dose painting by numbers for head and neck cancer: 3 years clinical results

被引：0
|
作者：
Berwouts, D. [1 ]
Duprez, F. [2 ]
Boterberg, T. [2 ]
De Gersem, W. [2 ]
Olteanu, A. M. L. [2 ]
Vercauteren, T. [2 ]
De Neve, W. [2 ]
机构：
[1] Univ Hosp Ghent, Radiat Oncol Nucl Med, Ghent, Belgium
[2] Univ Hosp Ghent, Radiat Oncol, Ghent, Belgium
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1149
引用
收藏
页码：S624 / S625
页数：2
相关论文
共 50 条
  • [41] Clinical results at 3 years of the ACCORD 12 randomized trial in rectal cancer.
    Gerard, Jean-Pierre
    Azria, David
    Gourgou-Bourgade, Sophie
    Conroy, Thierry
    Bedenne, Laurent
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [42] Safety and clinical benefit of reduced elective dose in head & neck cancer: results of a randomized controlled trial (NCT02442375)
    van den Bosch, S.
    Doornaert, P. A. H.
    Hoebers, F. J. P.
    Kreike, B.
    Vergeer, M. R.
    Dijkema, T.
    Zwijnenburg, E. M.
    Hannink, G.
    Kaanders, J. H. A. M.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1455 - S1459
  • [43] Trilynx: A Phase 3 Trial of Xevinapant and Concurrent Chemoradiotherapy (CRT) for Locally Advanced Head and Neck Cancer
    Schoenfeld, J. D.
    Cohen, E.
    Nutting, C. M.
    Licitra, L.
    Burtness, B.
    Omar, M.
    Bouisset, F.
    Nauwelaerts, H.
    Urfer, Y.
    Zanna, C.
    Bourhis, J., Sr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E20 - E21
  • [44] TrilynX: A phase 3 trial of xevinapant and concurrent chemoradiation for locally advanced head and neck cancer.
    Bourhis, Jean
    Burtness, Barbara
    Licitra, Lisa F.
    Nutting, Christopher
    Schoenfeld, Jonathan D.
    Sarkouh, Rafik Ait
    Bouisset, Florilene
    Nauwelaerts, Heidi
    Urfer, Yulia
    Zanna, Claudio
    Cohen, Ezra E. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Phase II Trial of Elective Nodal Dose 36 Gy for Advanced Head and Neck Cancer
    Maguire, Patrick D.
    Neal, Charles R.
    Adams, Ashley
    Hardy, Stuart M.
    Schreiber, Andrew M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E8 - E8
  • [46] HIGH DOSE METHOTREXATE AS A PREOPERATIVE ADJUVANT IN TREATMENT OF EPIDERMOID CARCINOMA OF HEAD AND NECK - FEASIBILITY STUDY AND CLINICAL TRIAL
    TARPLEY, JL
    CHRETIEN, PB
    ALEXANDER, JC
    HOYE, RC
    BLOCK, JB
    KETCHAM, AS
    AMERICAN JOURNAL OF SURGERY, 1975, 130 (04): : 481 - 486
  • [47] Long term results of phase 3 randomized study evaluating the addition of low dose nivolumab to palliative chemotherapy in head and neck cancer.
    Patil, Vijay Maruti
    Noronha, Vanita
    Menon, Nandini Sharrel
    Shah, Minit Jalan
    Peelay, Zoya Ravish
    Nawale, Kavita Prakash
    Bhagyavant, Priyanka
    Sawant, Riddhi
    Kolkur, Manali
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA6054 - LBA6054
  • [48] Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors (vol 55, pg 217, 2016)
    Differding, Sarah
    Sterpin, Edmond
    Janssens, Guillaume
    Hanin, Francois-Xavier
    Lee, John Aldo
    Gregoire, Vincent
    ACTA ONCOLOGICA, 2016, 55 (06) : 787 - 787
  • [49] Adaptive Radiotherapy for Head-and-Neck Cancer: Initial Clinical Outcomes From a Prospective Trial
    Schwartz, David L.
    Garden, Adam S.
    Thomas, Jimmy
    Chen, Yipei
    Zhang, Yongbin
    Lewin, Jan
    Chambers, Mark S.
    Dong, Lei
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (03): : 986 - 993
  • [50] Electrochemotherapy for mucosal head and neck tumours: results from a phase II clinical trial.
    Plaschke, C. C.
    Gehl, J.
    Johannesen, H.
    Hendel, H.
    Kiss, K.
    Hansen, R.
    Wessel, I.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 45 - 46
12345